Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 50

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations

Liu, Ruijie, Correll, Robert N., Davis, Jennifer, Vagnozzi, Ronald J., York, Allen J., Sargent, Michelle A., Nairn, Angus C., Molkentin, Jeffery D. · 2015 · Journal of Molecular and Cellular Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yjmcc.2015.08.018

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 53

  1. Ceulemans, 2004, Functional diversity of protein phosphatase-1, a cellular economizer and reset button, Physiol. Rev., 84, 1, 10.1152/physrev.00013.2003 · DOI · Paper page
  2. Le, 2011, Identification of AKAP79 as a protein phosphatase 1 catalytic binding protein, Biochemistry, 50, 5279, 10.1021/bi200089z · DOI
  3. Bollen, 2010, The extended PP1 toolkit: designed to create specificity, Trends Biochem. Sci., 35, 450, 10.1016/j.tibs.2010.03.002 · DOI · Paper page
  4. Alessi, 1992, The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1, Eur. J. Biochem. FEBS, 210, 1023, 10.1111/j.1432-1033.1992.tb17508.x · DOI · Paper page
  5. Terry-Lorenzo, 2002, Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton, J. Biol. Chem., 277, 46535, 10.1074/jbc.M206960200 · DOI
  6. Oliver, 2002, Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology, Mol. Cell. Biol., 22, 4690, 10.1128/MCB.22.13.4690-4701.2002 · DOI
  7. Ragusa, 2010, Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites, Nat. Struct. Mol. Biol., 17, 459, 10.1038/nsmb.1786 · DOI · Paper page
  8. Mizutani, 2010, Overexpression of myosin phosphatase reduces Ca(2+) sensitivity of contraction and impairs cardiac function, Circ. J., 74, 120, 10.1253/circj.CJ-09-0462 · DOI
  9. Yamada, 2006, Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy, FASEB J., 20, 1197, 10.1096/fj.05-5299fje · DOI
  10. Aoyama, 2011, Isoform-specific roles of protein phosphatase 1 catalytic subunits in sarcoplasmic reticulum-mediated Ca(2+) cycling, Cardiovasc. Res., 89, 79, 10.1093/cvr/cvq252 · DOI
  11. Carr, 2002, Type 1 phosphatase, a negative regulator of cardiac function, Mol. Cell. Biol., 22, 4124, 10.1128/MCB.22.12.4124-4135.2002 · DOI · Paper page
  12. Eschenhagen, 2010, Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?, J. Clin. Invest., 120, 4197, 10.1172/JCI45251 · doi:10.1172/jci45251
  13. Seguchi, 2007, A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart, J. Clin. Invest., 117, 2812, 10.1172/JCI30804 · DOI · Paper page
  14. Scruggs, 2010, A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain, Mol. Cell. Proteomics, 9, 1804, 10.1074/mcp.M110.000075 · DOI
  15. Sanbe, 1999, Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2, J. Biol. Chem., 274, 21085, 10.1074/jbc.274.30.21085 · DOI
  16. Scruggs, 2009, Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation, J. Biol. Chem., 284, 5097, 10.1074/jbc.M807414200 · DOI
  17. Karsai, 2013, Cross-species mechanical fingerprinting of cardiac myosin binding protein-C, Biophys. J., 104, 2465, 10.1016/j.bpj.2013.04.027 · DOI
  18. Sadayappan, 2006, Cardiac myosin binding protein C phosphorylation is cardioprotective, Proc. Natl. Acad. Sci. U. S. A., 103, 16918, 10.1073/pnas.0607069103 · DOI · Paper page
  19. Solaro, 2013, Integration of troponin I phosphorylation with cardiac regulatory networks, Circ. Res., 112, 355, 10.1161/CIRCRESAHA.112.268672 · DOI
  20. Metzger, 2004, Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation, Circ. Res., 94, 146, 10.1161/01.RES.0000110083.17024.60 · DOI · Paper page
  21. Kirchhefer, 2005, Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2, Cardiovasc. Res., 68, 98, 10.1016/j.cardiores.2005.05.019 · DOI
  22. Pathak, 2005, Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1, Circ. Res., 96, 756, 10.1161/01.RES.0000161256.85833.fa · DOI · Paper page
  23. Grote-Wessels, 2008, Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload, Cardiovasc. Res., 79, 464, 10.1093/cvr/cvn113 · DOI
  24. El-Armouche, 2008, Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy, Cardiovasc. Res., 80, 396, 10.1093/cvr/cvn208 · DOI
  25. Heijman, 2013, Function and regulation of serine/threonine phosphatases in the healthy and diseased heart, J. Mol. Cell. Cardiol., 64, 90, 10.1016/j.yjmcc.2013.09.006 · DOI
  26. Sinha, 2013, Selective ablation of Ppp1cc gene in testicular germ cells causes oligo-teratozoospermia and infertility in mice, Biol. Reprod., 89, 128, 10.1095/biolreprod.113.110239 · doi:10.1095/biolreprod.113.110239
  27. Moses, 2001, Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice, Genesis, 31, 176, 10.1002/gene.10022 · DOI · Paper page
  28. Sohal, 2001, Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein, Circ. Res., 89, 20, 10.1161/hh1301.092687 · DOI · Paper page
  29. Kehat, 2011, Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth, Circ. Res., 108, 176, 10.1161/CIRCRESAHA.110.231514 · DOI · Paper page
  30. Yin, 2010, Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution, Mol. Cell. Proteomics, 9, 497, 10.1074/mcp.M900275-MCP200 · DOI
  31. Wu, 2009, Plasma membrane Ca2+−ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents, J. Clin. Invest., 119, 976
  32. Coutu, 2005, Genetic manipulation of calcium-handling proteins in cardiac myocytes. II. Mathematical modeling studies, Am. J. Physiol. Heart Circ. Physiol., 288, H613, 10.1152/ajpheart.00425.2004 · DOI
  33. Davis, 2007, Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+−independent mechanical tone and acute myocyte remodeling, Circ. Res., 100, 1494, 10.1161/01.RES.0000268412.34364.50 · DOI
  34. Porterfield, 1985, Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements, J. Appl. Physiol., 107, 1693
  35. Liu, 2009, Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach, Circ. Res., 105, 194, 10.1161/CIRCRESAHA.109.195313 · DOI
  36. Oka, 2006, Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability, Circ. Res., 98, 837, 10.1161/01.RES.0000215985.18538.c4 · DOI · Paper page
  37. Maillet, 2010, Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function, J. Biol. Chem., 285, 6716, 10.1074/jbc.M109.056143 · DOI
  38. Scruggs, 2011, The significance of regulatory light chain phosphorylation in cardiac physiology, Arch. Biochem. Biophys., 510, 129, 10.1016/j.abb.2011.02.013 · DOI
  39. Satoh, 2006, Requirement of Rac1 in the development of cardiac hypertrophy, Proc. Natl. Acad. Sci. U. S. A., 103, 7432, 10.1073/pnas.0510444103 · DOI · Paper page
  40. Raake, 2008, G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure, Circ. Res., 103, 413, 10.1161/CIRCRESAHA.107.168336 · DOI
  41. Burkhoff, 2005, Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers, Am. J. Physiol. Heart Circ. Physiol., 289, H501, 10.1152/ajpheart.00138.2005 · DOI · Paper page
  42. Nicolaou, 2009, Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology, J. Mol. Cell. Cardiol., 47, 365, 10.1016/j.yjmcc.2009.05.010 · DOI
  43. Chiang, 2015, Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients, J. Am. Coll. Cardiol., 65, 163, 10.1016/j.jacc.2014.10.042 · DOI
  44. Miyazaki, 2012, Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling, PLoS ONE, 7, 10.1371/journal.pone.0035875 · DOI
  45. Sheikh, 2012, Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease, J. Clin. Invest., 122, 1209, 10.1172/JCI61134 · DOI
  46. Sheikh, 2014, Getting the skinny on thick filament regulation in cardiac muscle biology and disease, Trends Cardiovasc. Med., 24, 133, 10.1016/j.tcm.2013.07.004 · DOI
  47. Moss, 2015, Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium, Circ. Res., 116, 183, 10.1161/CIRCRESAHA.116.300561 · DOI
  48. Tong, 2014, Cardiac myosin-binding protein-C is a critical mediator of diastolic function, Pflugers Arch. - Eur. J. Physiol., 466, 451, 10.1007/s00424-014-1442-1 · DOI
  49. Kotlo, 2012, Phosphoprotein abundance changes in hypertensive cardiac remodeling, J. Proteome, 77, 1, 10.1016/j.jprot.2012.05.041 · DOI
  50. Yang, 2008, Cardiac myofilament regulation by protein phosphatase type 1alpha and CapZ, Biochem. Cell Biol., 86, 70, 10.1139/O07-150 · DOI
  51. Huang, 2012, Appreciating the strengths and weaknesses of transthoracic echocardiography in hemodynamic assessments, Cardiol. Res. Pract., 894308
  52. Kirkpatrick, 2007, Echocardiography in heart failure: applications, utility, and new horizons, J. Am. Coll. Cardiol., 50, 381, 10.1016/j.jacc.2007.03.048 · DOI · Paper page
  53. Nishimura, 2012, Hemodynamics in the cardiac catheterization laboratory of the 21st century, Circulation, 125, 2138, 10.1161/CIRCULATIONAHA.111.060319 · DOI · Paper page

Cited by

See all 50

Metadata

Authors
Liu, R., Correll, R. N., Davis, J., Vagnozzi, R. J., York, A. J., Sargent, M. A., Nairn, A. C., & Molkentin, J. D.
Venue
Journal of Molecular and Cellular Cardiology
Publisher
Elsevier BV
Published
2015-10
Volume
87
Pages
204-213
ISSN
0022-2828
Cited by
50
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.